Joseph Quinn, MD, Associate Professor of Neurology, Oregon Health and Science UniversityDr. Quinn has served as a neurologist clinician in the Oregon Alzheimer's Disease Center since 1994 and has served as Director of the Genetics and Biomarkers Core since 2007.Dr. Quinn's overall research focus is on developing strategies for treating and preventing Alzheimer's disease and other dementias. Specific research projects range from animal studies testing experimental agents, up to large national multi-center clinical trials of experimental drugs for dementing illnesses. The translation of ideas from the laboratory to the clinic is a particular interest, which is served in part by the Biomarkers core of the Oregon Alzheimer's Center. The Biomarkers Core helps develop blood tests and other disease markers for use in "proof of concept" clinical trials which are necessary to move treatment ideas from animal models to human subjects.

"This is an excellent overview of the differential diagnosis and treatment of patients with dementia. It provides practical tips to guide clinicians through the initial diagnosis, current treatment options, and long-term complexities of caring for patients with cognitive decline. The information is presented in a clinically relevant and concise manner. With further advances in neuroimaging, disease markers, and, hopefully, treatment options, more books like this will be needed to provide clinicians with up-to-date reviews of current practice guidelines." (Doody's, 13 February 2015)"The tone is practical, not academic, with authors offering assistance on what might be done and what should be avoided." (European Journal of Nuclear Medicine Molecular Imaging, 2015)

• Contributors viiSeries Foreword ixPreface xiChapter 1 Diagnosis and Differential Diagnosis of Dementia 1Richard CamicioliChapter 2 Rapidly Progressive Dementia and its Mimics 15Amy May Lin Quek and Andrew McKeonChapter 3 Young Onset Dementia: How Much Diagnostic Testing is Enough? 35Anahita Adeli and Keith A. JosephsChapter 4 An Approach to the Problem of Normal Pressure Hydrocephalus 55Norman RelkinChapter 5 Depression: Cause or Complication of Cognitive Decline? 67David Mansoor, Sahana Misra, and Linda GanziniChapter 6 Mild Cognitive Impairment 77Ranjan Duara, David A. Loewenstein, Clinton Wright, Elizabeth Crocco, and Daniel VaronChapter 7 After the Diagnosis: Continuing Neurological Care of the Outpatient with Dementia 97Anne M. LiptonChapter 8 Using Psychotropic Medications to Manage Problem Behaviors in Dementia 111Lucy Y. Wang and Murray A. RaskindChapter 9 Palliative Care in Advanced Dementias 121Ira Byock and Cory IngramChapter 10 Ethical, Legal, and Social Issues in Dementia 137Amy Y. Tsou and Jason KarlawishChapter 11 Assessing Outcomes in Dementia Care 151Joel Mack, Amie Peterson, and Joseph QuinnChapter 12 Primary Prevention of Dementia 163Joseph QuinnIndex 171

Joseph Quinn, MD, Associate Professor of Neurology, Oregon Health and Science UniversityDr. Quinn has served as a neurologist clinician in the Oregon Alzheimer's Disease Center since 1994 and has served as Director of the Genetics and Biomarkers Core since 2007.Dr. Quinn's overall research focus is on developing strategies for treating and preventing Alzheimer's disease and other dementias. Specific research projects range from animal studies testing experimental agents, up to large national multi-center clinical trials of experimental drugs for dementing illnesses. The translation of ideas from the laboratory to the clinic is a particular interest, which is served in part by the Biomarkers core of the Oregon Alzheimer's Center. The Biomarkers Core helps develop blood tests and other disease markers for use in "proof of concept" clinical trials which are necessary to move treatment ideas from animal models to human subjects.

"This is an excellent overview of the differential diagnosis and treatment of patients with dementia. It provides practical tips to guide clinicians through the initial diagnosis, current treatment options, and long-term complexities of caring for patients with cognitive decline. The information is presented in a clinically relevant and concise manner. With further advances in neuroimaging, disease markers, and, hopefully, treatment options, more books like this will be needed to provide clinicians with up-to-date reviews of current practice guidelines." (Doody's, 13 February 2015)"The tone is practical, not academic, with authors offering assistance on what might be done and what should be avoided." (European Journal of Nuclear Medicine Molecular Imaging, 2015)

• Contributors viiSeries Foreword ixPreface xiChapter 1 Diagnosis and Differential Diagnosis of Dementia 1Richard CamicioliChapter 2 Rapidly Progressive Dementia and its Mimics 15Amy May Lin Quek and Andrew McKeonChapter 3 Young Onset Dementia: How Much Diagnostic Testing is Enough? 35Anahita Adeli and Keith A. JosephsChapter 4 An Approach to the Problem of Normal Pressure Hydrocephalus 55Norman RelkinChapter 5 Depression: Cause or Complication of Cognitive Decline? 67David Mansoor, Sahana Misra, and Linda GanziniChapter 6 Mild Cognitive Impairment 77Ranjan Duara, David A. Loewenstein, Clinton Wright, Elizabeth Crocco, and Daniel VaronChapter 7 After the Diagnosis: Continuing Neurological Care of the Outpatient with Dementia 97Anne M. LiptonChapter 8 Using Psychotropic Medications to Manage Problem Behaviors in Dementia 111Lucy Y. Wang and Murray A. RaskindChapter 9 Palliative Care in Advanced Dementias 121Ira Byock and Cory IngramChapter 10 Ethical, Legal, and Social Issues in Dementia 137Amy Y. Tsou and Jason KarlawishChapter 11 Assessing Outcomes in Dementia Care 151Joel Mack, Amie Peterson, and Joseph QuinnChapter 12 Primary Prevention of Dementia 163Joseph QuinnIndex 171

Joseph Quinn, MD, Associate Professor of Neurology, Oregon Health and Science UniversityDr. Quinn has served as a neurologist clinician in the Oregon Alzheimer's Disease Center since 1994 and has served as Director of the Genetics and Biomarkers Core since 2007.Dr. Quinn's overall research focus is on developing strategies for treating and preventing Alzheimer's disease and other dementias. Specific research projects range from animal studies testing experimental agents, up to large national multi-center clinical trials of experimental drugs for dementing illnesses. The translation of ideas from the laboratory to the clinic is a particular interest, which is served in part by the Biomarkers core of the Oregon Alzheimer's Center. The Biomarkers Core helps develop blood tests and other disease markers for use in "proof of concept" clinical trials which are necessary to move treatment ideas from animal models to human subjects.

"This is an excellent overview of the differential diagnosis and treatment of patients with dementia. It provides practical tips to guide clinicians through the initial diagnosis, current treatment options, and long-term complexities of caring for patients with cognitive decline. The information is presented in a clinically relevant and concise manner. With further advances in neuroimaging, disease markers, and, hopefully, treatment options, more books like this will be needed to provide clinicians with up-to-date reviews of current practice guidelines." (Doody's, 13 February 2015)"The tone is practical, not academic, with authors offering assistance on what might be done and what should be avoided." (European Journal of Nuclear Medicine Molecular Imaging, 2015)

• Contributors viiSeries Foreword ixPreface xiChapter 1 Diagnosis and Differential Diagnosis of Dementia 1Richard CamicioliChapter 2 Rapidly Progressive Dementia and its Mimics 15Amy May Lin Quek and Andrew McKeonChapter 3 Young Onset Dementia: How Much Diagnostic Testing is Enough? 35Anahita Adeli and Keith A. JosephsChapter 4 An Approach to the Problem of Normal Pressure Hydrocephalus 55Norman RelkinChapter 5 Depression: Cause or Complication of Cognitive Decline? 67David Mansoor, Sahana Misra, and Linda GanziniChapter 6 Mild Cognitive Impairment 77Ranjan Duara, David A. Loewenstein, Clinton Wright, Elizabeth Crocco, and Daniel VaronChapter 7 After the Diagnosis: Continuing Neurological Care of the Outpatient with Dementia 97Anne M. LiptonChapter 8 Using Psychotropic Medications to Manage Problem Behaviors in Dementia 111Lucy Y. Wang and Murray A. RaskindChapter 9 Palliative Care in Advanced Dementias 121Ira Byock and Cory IngramChapter 10 Ethical, Legal, and Social Issues in Dementia 137Amy Y. Tsou and Jason KarlawishChapter 11 Assessing Outcomes in Dementia Care 151Joel Mack, Amie Peterson, and Joseph QuinnChapter 12 Primary Prevention of Dementia 163Joseph QuinnIndex 171